M. Högberg

发表

Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid

S. Höglund, Á. Végvári, J. Balzarini, 2009 .

Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology

S. Höglund, Á. Végvári, J. Balzarini, 2009, Retrovirology.

Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent

M. Kallio, L. Rickardson, S. Rehnmark, 2017, Drug design, development and therapy.

HIV-1 non-nucleoside reverse transcriptase inhibitors

M. Högberg, I. Morrison, 2000 .

Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.

L. Vrang, B. Oberg, J. Morin, 1996, Journal of medicinal chemistry.

Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.

J M Morin, J. Morin, S. Jaskunas, 1995, Journal of medicinal chemistry.

Bioisosteric modification of PETT-HIV-1 RT-inhibitors: synthesis and biological evaluation.

L. Vrang, M. Högberg, H. Zhang, 2000, Bioorganic & medicinal chemistry letters.

Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

L. Vrang, L Vrang, M Högberg, 1998, Bioorganic & medicinal chemistry letters.

New Heteroaromatic Complexing Agents and Luminescence of Their Europium(III) and Terbium(III) Chelates

J. Kankare, M. Kwiatkowski, H. Takalo, 1992 .

Derive du glycinamide destine a inhiber la replication du vih

J. Balzarini, M. Högberg, Weimin Tong, 2004 .

Composes inhibant le replication du virus de l'immunodeficience humaine

J. Balzarini, M. Högberg, Anders Vahlne, 2005 .

Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues.

L. Vrang, B. Oberg, T. Unge, 1999, Journal of medicinal chemistry.

evaluation of the antitumor activity of nOV202, a novel microtubule targeting and vascular disrupting agent

M. Kallio, L. Rickardson, S. Rehnmark, 2017 .